Dugo M, Huang CS, Egle D, Bermejo B, et al. The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer. Clin Cancer Res 2024 Sep 23:OF1-OF10. doi: 10.1158/1078-0432.CCR-24-0149.
PMID: 39308141